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The aim of the present work was to develop simple, accurate, sensitive and selective
methods for the simultaneous determination of oxomemazine (Ox), sodium benzoate (SB),
guaifenesin (Gu), andparacetamol (Par). Two methods were described and validated for the
simultaneous determination of the four drugs in syrup and suppositories. The first method
was a reversed phase HPLC and UVdetection at 220 nm. The assay was performed using C
18 column and an isocratic elution using acetonitrile e methanol e 35 mM KH2PO4 (20: 5:
75; by volume, pH was adjusted to 2.9 ± 0.1) as the mobile phase. The flow rate was 1.5 mL/
min and separation was achieved in less than 15 min. The second method was a TLC-
spectrodensitometric method, used to separate, identify and quantify the four drugs when
present in combination. The drugs were applied on silica gel plates and development was
made using methylene chloride- methanol- acetic acid- 33% ammonia (89: 8.4: 2: 0.6, by
volume) as a mobile phase. The bands of the four drugs were quantified by scanning
spectrodensitometricaly at 270 nm. The suggested chromatographic methods were vali-
dated and applied successfully to the analysis of the syrup and suppositories.
Copyright 2014, Beni-Suef University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Oxomemazine (Ox), Sodium Benzoate (SB), Guaifenesin (Gu)
and Paracetamol (Par) as components of multi-ingredient.F. Farid).
i-Suef University.
ity. Production and hostformulations (syrup and suppository) are useful in the treat-
ment of cough. Oxomemazine is an antihistamine and anti-
tussive of the phenothiazine chemical class; chemically
designated as 10-(3-Dimethylamino-2-methylpropyl)pheno-
thiazine 5,5-dioxide (Martindale, 2007). Sodium benzoate is aing by Elsevier B.V. All rights reserved.
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tory antiseptic; chemically designated as (2RS)-3-(2-
Methoxyphenoxy) propane-1,2-diol (BP, 2007). Paracetamol is
known for its analgesic and antipyretic properties; chemically
designated as N-(4-Hydroxyphenyl)acetamide (BP, 2007), as
shown in Fig. 1.
Few methods have been reported for the determination of
Ox including, colorimetric (Aminet al., 2008), chromatographic
(Hewala, 1994) and voltammetric (Elsied, 2012) methods.
USP (USP, 2007) describes a titrimetric method for the
determination of SB. Many analytical methods have been
published for the determination of SB based on spectropho-
tometric (Sowmya KV et al., 2011; Tang and Tan, 1998), che-
mometric (Korany et al., 2010; El-Gindy et al., 2005),
chromatographic (Kumar et al., 2012; Zhang et al., 2011;
Louchaichi et al., 2009b; Galli and Barbas, 2004), in addition
to electroanalytical methods (Peres et al., 1998).
Guaifenesin is an official drug in the BP (BP, 2007) and USP
(USP 30, 2007) and is a common ingredient in several cough
dosage forms. Guaifenesin has been determined mainly in the
presence of other drugs by spctrofluorimetric (Maher et al.,
2014) spectrophotometric (Bhattacharyya et al., 2013; Pappano
et al., 1997), chemometric (Korany et al., 2010; Donmez et al.,
2011), chromatographic (Kolhal et al., 2014; Abdelwahab and
Abdelaleem, 2013; Suneetha G et al., 2012; Younus et al., 2012;
Elkady, 2010; Louhaichi et al., 2009a; Denola et al., 2009) and
voltammetric (Tapsoba et al., 2005) methods.
Paracetamol is an official drug in the BP (BP, 2007) and USP
(USP 30, 2007). Numerous methods have been reported for the
determination of Par, including titrimetric (Florey, 1974, 1985),
electrochemical (Tyszczuk-Rottiko et al., 2014; Lu and Tsai,
2011; Habibi et al., 2011), spectrophotometric (Hoang et al.,
2014; Ali et al., 2011; Florey, 1974, 1985; Metwally et al., 2007),
fluorimetric (Florey, 1974), chromatographic (Younus et al.,
2012; Ali et al., 2011; Metwally et al., 2007; Yang et al., 2010;
Li et al., 2010; Hashem, 2010; Yadav et al., 2009) and chemo-
metric (Ali et al., 2011; Metwally et al., 2007; Samadi- Maydobi
and Hassani, 2010; El- Gindy et al., 2010) techniques.Fig. 1 e Structures of a. Oxomemazine, b. Sodium
benzoate, c. guaifenesin and d. Paracetamol.Only one method has been reported for the simultaneous
determination of the four drugs, the method used two-line
solvent delivery system HPLC (Hewala, 1994). The four drugs
were determined in syrup together with guaicol and 4-
aminophenol. Cough syrup was mixed with methanolic
metronidazole soln. (internal standard) and the soln. was
analyzed by HPLC on a column (250 4.6mm i.d.) of 5microm
C18 material with a guard column (50  4.6 mm i.d.) of the
same material and a mobile phase (1.5 mL/min) consisting of
aqueous 18% methanol at pH 3.9 for 12 min followed by
aqueous 80% methanol at the same pH for 10 min was used.
Detection was done at 235 nm.
In the present work, two methods are described for the
simultaneous determination of the four drugs. The drugswere
successfully determined by isocratic elution LCwhich requires
less time of analysis than gradient HPLC. TLC-
spectrodensitometric method was also suggested which has
the advantage of being of low cost and is a faster technique
when compared toHPLC. The twomethodswere applied to the
analysis of the drugs in their pharmaceutical dosage forms.2. Experimental
2.1. Samples
2.1.1. Pure samples
Oxomemazine and paracetamol were kindly supplied by
Amirya for Pharmaceutical industries, Alexandria, Egypt.
Guaifenesin was kindly supplied by Global Napi, 6- October,
Egypt and sodium benzoate was purchased from El Nasr
Pharmaceutical Chemicals Co., Abu Zabaal, Cairo, Egypt. The
purity of these drugs was certified to be 100.00, 99.50, 99.30,
and 100.00 for Ox, SB, Gu and Par respectively.
2.1.2. Pharmaceutical samples
 Toplexil syrupmanufactured by European Egyptian Pharm.
IND. AlexandriaeEgypt. Batch No. 8523225, labeled to
contain0.033 gofOxand0.666 gof eachofGu, SBandParper
100mLsyrupandwaspurchased fromthe localpharmacies.
 Rectoplexil suppositories manufactured by Amiriya for
Pharmaceutical Industries, AlexandriaeEgypt, under li-
cense of Rhone-Poulenc Rorer-Paris-France. Batch No.
573905, labeled to contain 3.3 mg Ox and 66.6 mg of each of
Gu, SB and Par per suppository and was purchased from
the local pharmacies.
2.2. Chemicals and reagents
 Methanol (E-Merck, Darmstadt F.R. Germany) and aceto-
nitrile (TEDIA, USA) were both HPLC grade.
 Deionized water was (Otsuka Co., A.R.E).
 Potassium dihydrogen phosphate and ammonia 33% were
analytical grade (El Nasr Pharmaceutical Chemicals Co.,
Abu Zabaal, Cairo, Egypt).
 Phosphoric acid (Riedel-de-H€aen, SigmaeAldrich Lab-
ochemikalien GmbH (Germany))
 Methylene chloride and acetic acid analytical grade-
(SDFCL, s d fine-chem. limited, Mumbai, India).
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 The HPLC system consisted of a pump L-7110 (La Chrom,
Merck, Hitachi, Interface D-7000 (La Chrom,Merck, Hitachi)
UV/Vis detector L-7420 (La Chrom, Merck, Hitachi) and a
Lichrosorb C18 column (4.6 250mm)with a particle size of
10 mm. A 50 mL Hamilton® microsyringe was used for injec-
tion. A pHmeter (Jenway 3310)was used for pHadjustment.
 For TLC-spectrodensitometry:
B CAMAG Linomat 5 autosampler (Switzerland).
B CAMAG microsyringe (100 mL).
B CAMAG TLC scanner 3 S/N 130319 operated with winCATS
software.
B Precoated silica gel aluminium plates 60F254 (ALLUGRAM)
SIL G/UV (MachereyeNagel, Germany) 20 cm  20 cm with
0.2 mm coating thickness.2.4. Chromatographic conditions
2.4.1. For RP-HPLC method
The HPLC separation and quantitation were made on Lichro-
sorb RP C18 analytical column. An isocratic mobile phase sys-
tem consisting of methanol e acetonitrile e 35 mM KH2PO4 (5:
20: 75, by volume, pHwas adjusted to 2.9± 0.1with phosphoric
acid)wasused.Themobilephasewasfiltered througha0.45mm
membrane filter (Millipore, Bangalore, India) and degassed by
Ultrasonicvibrationsprior touse.Thepumpwassetatconstant
flow rate of 1.5 mL/min (isocratic elusion) and 20 mL sample
volume were injected onto the column. All determinations
were performed at ambient temperature at 220 nm.
2.4.2. For TLC-spectrodensitometric method
Sampleswere applied in the formof bands of 6mmwidthwith
a 100 mL sample syringe on TLC plates (20  10 cm), using a
constant application rate of 0.1 mL/s. The space between bands
was 12.1 mm. The slit dimension was 6.0  0.3 mm, and the
scanning speed was 20 mm/s. The mobile phase consisted of
methylene chloride emethanol e ammonia e acetic acid (89:
8.4: 0.6: 2, by volume, the pHof glacial acetic acid and ammonia
was 4 ± 0.2), and 100 mL mobile phase was used/chromato-
graphic run. Linear ascending development was carried out in
a glass chamber (MachereyeNagel) saturated with the mobile
phase. Development of the plateswas left till themobile phase
migrates 8 cm. Following the development, the plates were air
dried, bands were visualized under UV lamp at 254 nm and
densitometric scanning was performed at 270 nm.
2.5. Standard solutions and calibration
2.5.1. For RP-HPLC
Stock standard solutions (1 mg/mL) of Ox, SB, Gu and Par were
prepared by accurately weighing 100 mg of each compound
into a 100-mL volumetric flask. The four components were
dissolved in the mobile phase and the volumes were
completed to the mark with the same solvent.Working standard solutions of Ox, SB, Gu and Par (200 mg/
mL) was prepared by transferring 10 mL of Ox, SB, G and Par
stock standard solution separately, into four 50mL volumetric
flasks. The volume of each flask was completed to the mark
with the mobile phase.
Aliquots of Ox, SB, Gu and Par were separately transferred
eachfromitsrespectiveworkingstandardsolution (200mg/mL)
into four sets of 10-mL measuring flasks and the volume was
completed to the mark with the mobile phase. The final con-
centration rangeswere 1e50 mg/mL, 5e100 mg/mL, 2e100 mg/mL
and 5e150 mg/mL for Ox, SB, Gu and Par, respectively.
Triplicate 20 mL injections were made for each concentra-
tion and chromatographed under the specified chromato-
graphic conditions previously described. The relative peak
area values (using 10 mg/mL for Ox, 50 mg/mL for SB, 20 mg/mL
for Gu and 20 mg/mL for Par as external standards) were
plotted against the corresponding concentrations and
regression equations were computed.
2.5.2. For TLC-spectronensitometric method
Stock standard solutions (1 mg/mL) of Ox, SB, Gu and Par were
prepared by dissolving in methanol.
2.5.3. Calibration for TLC spectrodensitometric method
Aliquots of stock standard solutions (1 mg/mL) equivalent to
0.2e1.2 mg for Ox, 0.5e5 mg for Par, 0.5e5 mg for Gu and
0.5e3.5 mg for SB were transferred to four series of 10 mL
volumetric flasks. The volume of each flask was completed to
the mark with methanol and 10 mL from each solution was
applied in triplicates on TLC plates. The plates were developed
in the mobile phase consisting of methylene chloride emeth-
anole ammonia e glacial acetic acid (89: 8.4: 0.6: 2, by volume)
andscannedat 270nm.Thecalibration curves representing the
relationship between the relative peak areas (using an external
standard of 0.4 mg/bandofOx and 2 mg/bandof each Par, Gu and
SB)and thecorrespondingconcentrationswereplottedforeach
drug and the regression equations were computed.
2.6. Assay of laboratory prepared mixtures
Solutions containing different ratios of the four drugs in the
calibration range for each method were prepared. The con-
centrations were calculated from the corresponding regres-
sion equations.
2.7. Application to pharmaceutical preparations
Accurate volume of syrup was transferred, measured and
diluted to 100 mL of mobile phase in case of RP-HPLC method
and methanol in case of TLC method, the solution was then
filtered and further dilutions were done.
For rectoplexil® suppositories, six suppositories were trans-
ferred into a beaker and 60 mL methanol were added, the
mixturewasmelted inahotwaterbath for15mintodissolvethe
active ingredients. It was cooled and filtered through a filter
paper previously wetted with methanol into a 100 mL volu-
metric flask, the solid fatty residue was then returned to the
beaker and 20 mL methanol were added and the process was
repeated twice. The volume was completed to the mark with
methanol. Furtherdilutionsweredoneaccording to themethod.
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Table 1 eValidation results of the proposed HPLC and TLC-spectrodensitometric methods for the determination of oxomemazine (Ox), sodium benzoate (SB), guaifenesin
(Gu) and paracetamol (Par).
Parameters HPLC TLC e spectrodensitometry
Ox SB Gu Par Ox SB Gu Par
Calibration
Range 1e50 (mg/mL) 5e100 (mg/mL) 2e100 (mg/mL) 5e150 (mg/mL) 0.2e1.2 (mg/band) 0.5e3.5 (mg/band) 0.5e5 (mg/band) 0.5e5 (mg/band)
Slope (a) 0.0975 0.0198 0.0496 0.0491 1.7079 0.3028 0.0468, 0.5784* 0.0418, 0.5051*
Intercept (b) 0.0355 0.0144 0.0071 0.0281 0.3289 0.3955 0.0314 0.1423
Correlation Coefficient (r) 1.000 1.000 0.9998 0.9999 0.9992 0.9998 0.9998 0.9998
Accuracy (mean ± RSD%) 100.13 ± 1.171 100.24 ± 1.042 100.10 ± 1.719 99.95 ± 1.168 99.67 ± 1.706 99.72 ± 1.449 100.21 ± 1.365 100.06 ± 1.231
Specificity (mean ± RSD%) 100.24 ± 0.723 100.37 ± 0.429 99.88 ± 0.649 100.02 ± 0.857 99.44 ± 1.343 101.21 ± 0.621 100.17 ± 1.309 100.50 ± 0.703
Precision (%RSD)
Repeatability (%RSD) 1.192 0.950 0.761 1.098 1.785 1.143 1.063 1.445
Intermediate precision (%RSD) 1.381 1.624 0.856 1.326 1.544 1.754 1.541 1.688
Regression equations for Guaifenesin and Paracetamol by TLC-spectrodensitometry follow second order equation:
For Guaifenesin: Y ¼ 0.0468C2 þ 0.5784C þ 0.0314.
For Paracemol: Y ¼ 0.0418C2 þ0.5051C þ 0.1423.
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Fig. 3 e TLC Chromatogram of laboratory prepared mixture containing 0.2 mg/band Oxomemazine (Ox) (Rf¼ 0.13), 4 mg/band
Paracetamol (Par) (Rf ¼ 0.33), 2 mg/band Guaifenesin (Gu) (Rf ¼ 0.48) and 4 mg/band Sodium benzoate (SB) (Rf ¼ 0.66) using a
mobile phase consisting of methylene chloride e methanol e ammonia e glacial acetic acid (89:8.4:0.6:2, by volume).
b e n i - s u e f un i v e r s i t y j o u rn a l o f b a s i c a n d a p p l i e d s c i e n c e s 3 ( 2 0 1 4 ) 2 6 0e2 6 8264isocratic HPLC method, which requires a reasonable time of
analysis.
According to the Hewala method (Hewala, 1994), the sys-
tem consisting of methanol and water in a ratio of (18:82, v/v,
pH 3.9), separated the first three peaks of Par, Gu and SB,
however, the peak of Ox was eluted after more than 90 min.
On the other hand a system of methanol-water in a ratio of
(80: 20, v/v, pH 3.9), eluted Ox after 20 min, but the other three
drugs were eluted as a mass of non resolved peaks.
To optimize the proposed HPLC method, the type of col-
umn and its dimension, solvents used, fraction of organic
solvents in the mobile phase, normality of buffer used, pH,
detection wavelength and flow rate were varied. Different
types of stationary phases with different dimensions and
particle sizes were used. It was found that Lichrosorb C18Table 2 e Quantitative determination of oxomemazine (Ox), so
in pharmaceutical dosage forms by the proposed methods and
Dosage form Compound HPLC
Found ± RSD%
st
Toplexil Syrup
B.No. 8523226
Oxomemazine 99.59 ± 0.976
Sodium benzoate 100.58 ± 1.784
Guaifenesin 101.86 ± 0.555
Paracetamol 97.90 ± 1.294
Rectoplexil
Suppositories
B.No. 573905
Oxomemazine 100.47 ± 1.915
Sodium benzoate 100.68 ± 1.802
Guaifenesin 100.43 ± 1.665
Paracetamol 99.05 ± 0.638column (4.6  250 mm, with a particle size 10 mm) gave the
most suitable resolution. Addition of acetonitrile instead of
methanol to the mobile phase resulted in sharper peaks with
better resolution up to 20%. A system consisting of methanol
e acetonitrile e 35 mM KH2PO4, (5: 20: 75, by volume, pH
2.9 ± 0.1, flow rate 1.5 mL/min and detection at 220 nm),
resolved the four peaks with maximum resolution and mini-
mum time of analysis. Increasing the pH resulted in overlap
between the two peaks of SB and Ox.
Different wavelengths were tried to obtain optimum
sensitivity e.g. 270 nm, 250 nm and 220 nm. The wavelength
220 nm was chosen as it gave symmetrical peaks for the four
drugs with high sensitivity.
Upon applying the proposed HPLC under optimum
experimental conditions, good separation between the fourdium benzoate (SB), guaifenesin (Gu) and paracetamol (Par)
application of standard addition technique.
TLC spectro-densitometry
Recovery % of
andard addition
Found ± RSD% Recovery % of
standard addition
99.79 ± 0.550 100.30 ± 1.887 100.39 ± 1.571
99.68 ± 0.340 100.70 ± 1.994 100.00 ± 1.000
99.55 ± 1.130 100.59 ± 1.136 99.33 ± 1.528
101.10 ± 0.040 98.13 ± 0.953 101.20 ± 0.346
99.17 ± 0.827 100.91 ± 1.771 99.28 ± 1.014
99.38 ± 1.340 101.13 ± 0.420 99.17 ± 0.289
100.85 ± 0.747 100.94 ± 1.618 101.44 ± 0.768
100.58 ± 1.066 99.37 ± 0.824 98.93 ± 0.503
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curve was constructed representing the relation between
the relative peak area (using external standard of 10 mg/mL
Ox, 50 mg/mL for SB and 20 mg/mL for each of Gu and Par) and
concentration, for each drug. The regression equations were
computed for each drug. Calibration was found to be in the
ranges 1e5 mg/mL, 5e100 mg/mL, 2e100 mg/mL and 5e150 mg/
mL for Ox, SB, Gu and Par, respectively, Table 1.
The retention times of the four drugs were 8.7, 6.05, 4.05
and 2.50 min for Ox, SB, Gu and Par, respectively.
3.2. Optimization of the TLC-spectrodensitometric
method
Studying the optimum conditions for the maximum sepa-
ration of the four studied drugs was carried out by trying
different developing systems with different ratios. Initially,
methylene chloride and methanol were tried. Then inclu-
sion of ammonia and acetic acid was done. The pH of the
system is the main factor that affects the two spots of SB
and Ox. Complete separation of the four drugs with good Rf
values was achieved by using methylene chloride e meth-
anol e ammonia e acetic acid (89: 8.4: 0.6: 2, by volume).
This system resulted in Rf values (0.13, 0.33, 0.48, 0.66 for
Ox, Par, Gu and SB, respectively) with complete resolution.
Different wavelengths were tried to obtain optimum
sensitivity e.g. 270 nm, 250 nm and 220 nm. Scanning was
done at 270 nm where the four drugs showed sharp sym-
metrical compact peaks with good response, as shown in
Fig. 3.
Saturation of the glass chamber with themobile phase was
also important; it was found that 45 min were enough for
saturation. The plates were developed for a distance of 9 cm,
which took approximately 30 min.
The calibration curves were constructed by plotting the
relative peak areas (using 0.4 mg/band of Ox and 2 mg/band of
each of SB, Gu and Par as external standard) versus the cor-
responding concentrations for each of the four drugs. Cali-
bration was found to be in the ranges 0.2e1.2 mg/band,
0.5e3.5 mg/band, 0.5e5 mg/band and 0.5e5 mg/band for Ox, SB,
Gu and Par, respectively, Table 1.
The proposed methods were applied successfully to the
analysis of the four drugs in syrup and suppositories. The
validity of the proposed methods was assessed by applying
the standard addition technique. Results are shown in Table 2.Table 3 e System suitability parameters for oxomemazine (Ox
(Par) of the proposed HPLC and TLC-spectrodensitometric met
Parameter HPLC method
Ox SB Gu
Retention time tR (HPLC) or
retardation factor (Rf) (HPTLC)
8.7 ± 0.2 6.05 ± 0.1 4.05 ± 0.1
Resolution (Rs) 3.21 3.60 3.14
Tailing Factor (T) 1.52 1.22 1.28
Capacity Factor (K0) 4.118 2.559 1.382
Selectivity (a) 1.610 1.852 2.934
Column Efficiency (N) 1771.11 1329.12 1263.18
Height Equivalent to
theoretical plate (HETP)
0.1412 0.1881 0.19793.3. Method validation
Validation was done according to USP guidelines (USP, 2007).
3.4. Calibration and range
Relative peak area (using 10 mg/mL for Ox, 50 mg/mL for SB,
20 mg/mL for Gu and 20 mg/mL for Par as external standards)
was plotted versus the corresponding concentration. Cali-
bration curve showed good relationship and the ranges are
shown in Table 1.
3.5. Accuracy
The accuracy of the suggested methods was checked by
applying the proposed methods for the determination of
different unknown pure samples of Ox, SB, Gu and Par. The
concentrations were obtained from the corresponding
regression equations. The mean percentage recoveries were
found to be 100.13 ± 1.171, 100.24 ± 1.042, 100.10 ± 1.719 and
99.95 ± 1.168 for Ox, SB, G and Par, respectively by HPLC
method and 99.67 ± 1.706, 99.72 ± 1.449, 100.21 ± 1.365 and
100.06 ± 1.231 for Ox, SB, Gu and Par, respectively by TLC-
spectrodensitometric method as shown in Table 1.
Accuracy of the method was further assessed by the use of
the standard addition technique and the resulting mixtures
were analyzed by the proposedmethods. The results obtained
were comparedwith the expected results. The good recoveries
of the standard addition technique suggest good accuracy of
the methods as shown in Table 2.
3.6. Precision
3.6.1. Repeatability
The concentrations of (10, 20 and 30 mg/mL) Ox, (20, 50 and
66 mg/mL) SB, (20, 30 and 66 mg/mL) Gu and (50, 66 and 100 mg/
mL) for HPLCmethod and of (0.4, 0.6, 0.8 mg/band) Ox and of (1,
2 and 3 mg/band) for each of Par, Gu and SB for TLC-
spectrodensitometric method were analyzed three times
intra-daily using the proposedmethods. The relative standard
deviation was calculated and shown in Table 1.
3.6.2. Intermediate precision
The previous procedures were repeated on three different
days for the analysis of the chosen concentrations. The), sodium benzoate (SB), guaifenesin (Gu) and paracetamol
hod.
TLC-Spectrodensitometric method
Par Ox Par Gu SB
2.5 ± 0.1 0.13 0.33 0.48 0.66
3.83 2.29 3.09
1.29 1.13 1.17 1.05 1.13
0.471
2.54 1.46 1.38
1111.11
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Table 1.
3.7. Specificity
Specificity of the proposed methods is evident from RP-HPLC
and TLC Chromatograms in Figs. 2 and 3, respectively. Also
the proposed methods were applied for the determination of
the studied drugs in laboratory prepared mixtures containing
the four drugs within the calibration ranges. Satisfactory re-
sults were obtained as shown in Table 1.
3.8. Stability
The stock solutions of the four drugs showed no spectropho-
tometric changes for one week when stored in the
refrigerator.
3.9. Robustness
Robustness of the proposed method was evaluated in the
development phase, where the effect of different factors on
RP-HPLC and TLC spectrodensitometric methods were stud-
ied to obtain the optimum parameters for complete
separation.
3.10. System suitability for chromatographic methods
The system suitability for HPLC and TLC methods was based
on a concept that the equipment, electronics, analytical op-
erations and samples constitute an integral system that can
be evaluated as a whole. System suitability is used to ensure
system performance before or during the analysis of the
studied drugs.
System suitability was checked by calculating the resolu-
tion (Rs), tailing factor (T), capacity factor ((K0) and selectivity
factor (a) and the systemwas found to be suitable as shown in
Table 3.
Statistical analysis of the results obtained by the two sug-
gestedmethods and the reported referencemethod of the four
drugs Ox (Hewala, 1994), SB (Galli and Barbas, 2004), Gu
(Louhaichi et al., 2009a) and Par (BP, 2007), were carried out,
the calculated t and F values were less than the theoretical
ones (using a probability of 95%), which indicates that there is
no significance difference between the proposedmethods and
the reported reference methods with respect to accuracy and
precision, Table 4.T
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d4. Conclusion
Results obtained by the two proposed methods are reliable,
accurate and precise. Hence both methods can be employed
for routine quality control analysis with high accuracy and
precision. For bothmethods, prior separation of one drug from
another is not required as the proposed methods provided
high resolution of the four drugs. Therefore, bothmethods can
be used for the determination of the four drugs in combined
dosage forms. The two proposedmethods have the advantage
of being less time consuming and also TLC-
b e n i - s u e f u n i v e r s i t y j o u r n a l o f b a s i c a n d a p p l i e d s c i e n c e s 3 ( 2 0 1 4 ) 2 6 0e2 6 8 267spectrodensitometric method is considered to be a low cost
technique.
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